Congressional oversight is becoming a boardroom issue

Congressional investigations have emerged as a significant source of legal, regulatory, and reputational risk for private-sector organizations. During the 119th Congress, committees have expanded their focus beyond government agencies to include public companies, private businesses, universities, nonprofits, and individual executives. Investigators have increasingly scrutinized corporate governance, compliance programs, pricing practices, and internal decision-making, resulting in a growing volume of hearings, subpoenas, and document preservation and investigative letters. As the 2026 midterm elections approach, companies should be looking beyond today’s investigations and considering what Congress may prioritize beginning in January 2027.

A Democratic Congress would mean new investigative targets

A Democratic majority would likely prioritize congressional oversight over corporate accountability, consumer protection, and industries perceived to have benefited from Trump administration policies. While much of the investigative infrastructure already exists, the focus and targets could shift significantly.

Focus on entities and individuals perceived as aligned with the administration. One of the most consequential changes would be increased scrutiny of companies and individuals that are viewed as having received favorable treatment under the current administration or are otherwise perceived as aligned with it. Potential targets include entities that benefited from deregulation, obtained significant government contracts, received favorable enforcement outcomes, or secured regulatory relief that later became controversial. Industries likely to attract particular attention include energy, defense contracting, financial services, and major technology companies. Organizations operating in these sectors should evaluate whether prior interactions with executive branch agencies could become the subject of congressional inquiry.

Expanding the definition of corporate accountability. Democratic committee leadership is also likely to broaden oversight beyond traditional fraud and compliance issues. Investigations may increasingly focus on executive compensation, corporate governance, consumer impacts, and business practices that contribute to affordability concerns. Health care illustrates this shift: While Republican committees have largely focused on Medicaid fraud, state-level administration, and related health care spending issues, a Democratic Congress would likely concentrate on health care supply chains, including market concentration and pricing practices. Existing investigative tools and committee expertise would likely be redirected rather than abandoned.

Technology companies remain in the spotlight. Technology companies should expect continued scrutiny, particularly in the areas of artificial intelligence (AI), data privacy, and cybersecurity. Although AI oversight enjoys bipartisan support, a Democratic majority is likely to focus more heavily on consumer harm, algorithmic discrimination, workplace impacts, and corporate accountability following data breaches. Congressional committees may also use investigations to build support for comprehensive federal privacy legislation by highlighting perceived gaps in existing regulatory frameworks. Companies that collect, process, or monetize large volumes of consumer data should anticipate increased attention to their governance and cybersecurity practices.

Affordability as an oversight theme. Consumer affordability is likely to serve as a theme across multiple committees. Areas that could attract attention include algorithmic pricing practices, housing costs, utility rates associated with growing data-center demand, auto lending practices, health care expenses, and other issues affecting household budgets.

Many Democratic lawmakers have raised concerns and previewed likely efforts focused on these areas. Committee control would provide the subpoena authority and the ability to set the agenda for hearings necessary to pursue those concerns more aggressively.

The issues that will persist in 2027

Not every oversight priority will change with a potential new majority. Several issues have attracted sustained bipartisan interest and are likely to remain active regardless of which party controls Congress.

Artificial intelligence: The defining oversight issue. AI is poised to remain one of Congress’s most significant oversight priorities. Although Republicans and Democrats have emphasized different risks – from content moderation and foreign influence to algorithmic pricing and workforce displacement – both parties view AI as an area requiring sustained scrutiny. As AI systems become increasingly embedded in commercial operations, companies should expect continued congressional interest in transparency, accountability, competition, and consumer protection.

Data privacy and cybersecurity. Data privacy and cybersecurity are similarly positioned as enduring bipartisan concerns. The rapid deployment of AI systems, coupled with increasingly sophisticated cyber threats using AI, has heightened concerns about the adequacy of existing data-protection frameworks. Absent comprehensive federal privacy legislation, congressional committees are likely to continue using oversight investigations to examine corporate cybersecurity failures and data governance practices.

Health care costs and drug pricing. Health care affordability has attracted consistent attention from both parties, particularly regarding prescription drug pricing and the role of Pharmacy Benefit Managers. Multiple House and Senate committees are already conducting investigations in this area, making it likely that oversight will continue regardless of election outcomes. Moreover, concerns about waste, fraud, and abuse in government programs, contracts, and procurement are prevalent on both sides of the aisle.

National security and China-related risks. Concerns involving China, supply-chain resilience, technology transfer, and foreign influence are also expected to remain bipartisan priorities.

Preparing before the first request, letter, or subpoena arrives

Companies should begin preparing now by assessing whether their operations, government relationships, or prior regulatory interactions align with likely investigative priorities. Organizations that benefited from deregulation, government contracts, or perceived favorable enforcement decisions from the Trump administration should conduct a candid evaluation of potential exposure. Because congressional investigations often begin with informal staff outreach, preservation letters, document requests, or investigative letters, companies should establish a coordinated response framework involving legal, compliance, government affairs, and communications personnel. Businesses should also closely monitor statements by committee leaders, oversight reports, hearing agendas, and public correspondence in the months leading up to and following the midterm elections, as these often provide the earliest signals of future investigative activity. Companies that assess their risk profiles and prepare response protocols now will be better positioned to manage the legal, regulatory, and reputational challenges that accompany congressional scrutiny.

We are actively monitoring these developments and assisting with risk assessments related to these issues and are available to assist clients in assessing their unique risk profile, preparing for congressional inquiries, and developing coordinated response strategies.

Client Alert 2026-139